Childhood Absence Epilepsy Rx PK-PD-Pharmacogenetics Study
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Avital Cnaan, PhD
Children's National Research Institute
Principal Investigator - Peter Adamson, MD
Children's Hospital of Philadelphia
Principal Investigator - Tracy A. Glauser, MD
Children's Hospital Medical Center, Cincinnati
Principal InvestigatorKOL profile →
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
31 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- the Children'S Hospital of Alabama
Birmingham, Alabama, United States
- St. Joseph'S Hospital and Medical Center
Phoenix, Arizona, United States
- Arkansas Children'S Hospital
Little Rock, Arkansas, United States
- University of California at San Diego
La Jolla, California, United States
- Mattel Children'S Hospital at Ucla
Los Angeles, California, United States
- Children'S Hospital of Denver
Denver, Colorado, United States
- Yale University School of Medicine
New Haven, Connecticut, United States
- Children'S National Medical Center
Washington D.C., District of Columbia, United States
- Nemours Children'S Clinic
Jacksonville, Florida, United States
- Miami Children'S Hospital
Miami, Florida, United States
- Children'S Healthcare of Atlanta
Atlanta, Georgia, United States
- Children'S Memorial Hospital
Chicago, Illinois, United States
- Children'S Hospital of Michigan
Detroit, Michigan, United States
- Washington University in St. Louis
St Louis, Missouri, United States
- Women and Children'S Hospital of Buffalo
Buffalo, New York, United States
- Nyu Comprehensive Epilepsy Center, Manhattan
New York, New York, United States
- Montefiore Medical Center
The Bronx, New York, United States
- Cincinnati Children'S Hospital
Cincinnati, Ohio, United States
- Rainbow Babies & Children'S Hospital
Cleveland, Ohio, United States
- Children'S Hospital, Inc., Pcti
Columbus, Ohio, United States
- Doernbecher Children'S Hospital
Portland, Oregon, United States
- Children'S Hospital of Philadelphia
Philadelphia, Pennsylvania, United States
- Children'S Hospital of Pittsburgh
Pittsburgh, Pennsylvania, United States
- Lebonheur Children'S Medical Center
Memphis, Tennessee, United States
- Dallas Pediatric Neurology Associates
Dallas, Texas, United States
- Cook Children'S Medical Center
Fort Worth, Texas, United States
- Texas Children'S Hospital
Houston, Texas, United States
- University of Utah/primary Children'S Medical Center
Salt Lake City, Utah, United States
- Children'S Hospital of the King'S Daughter (monarch Medical Research)
Norfolk, Virginia, United States
- Children'S Hospital & Regional Medical Center
Seattle, Washington, United States
- Children'S Hospital of Wisconsin
Milwaukee, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Jul 2004
- Primary completion
- 31 Jan 2013
- Completion
- 31 Aug 2016
- Last update posted
- 14 Oct 2020
- Registered enrollment
- 453
- Registry id
- NCT00088452
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.